413 related articles for article (PubMed ID: 34757220)
1. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
[TBL] [Abstract][Full Text] [Related]
2. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
Bone Marrow Transplant; 2022 Jul; 57(7):1150-1163. PubMed ID: 35523848
[TBL] [Abstract][Full Text] [Related]
3. Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Inamoto Y; Petriček I; Burns L; Chhabra S; DeFilipp Z; Hematti P; Rovó A; Schears R; Shah A; Agrawal V; Ahmed A; Ahmed I; Ali A; Aljurf M; Alkhateeb H; Beitinjaneh A; Bhatt N; Buchbinder D; Byrne M; Callander N; Fahnehjelm K; Farhadfar N; Gale RP; Ganguly S; Hashmi S; Hildebrandt GC; Horn E; Jakubowski A; Kamble RT; Law J; Lee C; Nathan S; Penack O; Pingali R; Prasad P; Pulanic D; Rotz S; Shreenivas A; Steinberg A; Tabbara K; Tichelli A; Wirk B; Yared J; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Valdés-Sanz N
Biol Blood Marrow Transplant; 2019 May; 25(5):e145-e154. PubMed ID: 30521975
[TBL] [Abstract][Full Text] [Related]
4. Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Inamoto Y; Valdés-Sanz N; Ogawa Y; Alves M; Berchicci L; Galvin J; Greinix H; Hale GA; Horn B; Kelly D; Liu H; Rowley S; Schoemans H; Shah A; Lupo Stanghellini MT; Agrawal V; Ahmed I; Ali A; Bhatt N; Byrne M; Chhabra S; DeFilipp Z; Fahnehjelm K; Farhadfar N; Horn E; Lee C; Nathan S; Penack O; Prasad P; Rotz S; Rovó A; Yared J; Pavletic S; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Petriček I
Biol Blood Marrow Transplant; 2019 Feb; 25(2):e46-e54. PubMed ID: 30481594
[TBL] [Abstract][Full Text] [Related]
5. Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
Inamoto Y; Petriček I; Burns L; Chhabra S; DeFilipp Z; Hematti P; Rovó A; Schears R; Shah A; Agrawal V; Al-Khinji A; Ahmed I; Ali A; Aljurf M; Alkhateeb H; Beitinjaneh A; Bhatt N; Buchbinder D; Byrne M; Callander N; Fahnehjelm K; Farhadfar N; Gale RP; Ganguly S; Hildebrandt GC; Horn E; Jakubowski A; Kamble RT; Law J; Lee C; Nathan S; Penack O; Pingali R; Prasad P; Pulanic D; Rotz S; Shreenivas A; Steinberg A; Tabbara K; Tichelli A; Wirk B; Yared J; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Valdés-Sanz N
Bone Marrow Transplant; 2019 May; 54(5):648-661. PubMed ID: 30531955
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Loren AW; Chow E; Jacobsohn DA; Gilleece M; Halter J; Joshi S; Wang Z; Sobocinski KA; Gupta V; Hale GA; Marks DI; Stadtmauer EA; Apperley J; Cahn JY; Schouten HC; Lazarus HM; Savani BN; McCarthy PL; Jakubowski AA; Kamani NR; Hayes-Lattin B; Maziarz RT; Warwick AB; Sorror ML; Bolwell BJ; Socié G; Wingard JR; Rizzo JD; Majhail NS
Biol Blood Marrow Transplant; 2011 Feb; 17(2):157-66. PubMed ID: 20659574
[TBL] [Abstract][Full Text] [Related]
7. Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
Inamoto Y; Valdés-Sanz N; Ogawa Y; Alves M; Berchicci L; Galvin J; Greinix H; Hale GA; Horn B; Kelly D; Liu H; Rowley S; Schoemans H; Shah A; Lupo Stanghellini MT; Agrawal V; Ahmed I; Ali A; Bhatt N; Byrne M; Chhabra S; DeFilipp Z; Fahnehjelm K; Farhadfar N; Horn E; Lee C; Nathan S; Penack O; Prasad P; Rotz S; Rovó A; Yared J; Pavletic S; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Petriček I
Bone Marrow Transplant; 2019 May; 54(5):662-673. PubMed ID: 30531954
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
Kelly DL; Buchbinder D; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick A; Wirk BM; Yi J; Battiwalla M; Flowers ME; Savani B; Shaw BE
Biol Blood Marrow Transplant; 2018 Feb; 24(2):228-241. PubMed ID: 28939455
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
Buchbinder D; Kelly DL; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick AB; Wirk BM; Yi J; Battiwalla M; Flowers MDE; Savani B; Shaw BE
Bone Marrow Transplant; 2018 May; 53(5):535-555. PubMed ID: 29343837
[TBL] [Abstract][Full Text] [Related]
12. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
[TBL] [Abstract][Full Text] [Related]
13. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
14. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
[TBL] [Abstract][Full Text] [Related]
15. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
16. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M; Guilcher G; Thompson A; Shenoy S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1695-1700. PubMed ID: 28627425
[TBL] [Abstract][Full Text] [Related]
18. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
[TBL] [Abstract][Full Text] [Related]
19. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
[TBL] [Abstract][Full Text] [Related]
20. Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.
Kimura SI; Kameda K; Harada K; Saburi M; Okinaka K; Shinohara A; Uchida N; Nishijima A; Ozawa Y; Tanaka M; Kuriyama T; Katayama Y; Sawa M; Ikegame K; Kawakita T; Kanda Y; Nakamae H; Ara T; Kimura T; Sato A; Fukuda T; Atsuta Y; Nakasone H
Transplant Cell Ther; 2022 Apr; 28(4):209.e1-209.e9. PubMed ID: 34995815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
